688278 Stock Overview
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Xiamen Amoytop Biotech Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥59.85 |
| 52 Week High | CN¥69.97 |
| 52 Week Low | CN¥31.01 |
| Beta | 0.36 |
| 1 Month Change | -10.05% |
| 3 Month Change | 9.92% |
| 1 Year Change | 33.21% |
| 3 Year Change | 70.85% |
| 5 Year Change | n/a |
| Change since IPO | 69.55% |
Recent News & Updates
Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 04
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk
Mar 25Shareholder Returns
| 688278 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -8.4% | 0.3% | 1.6% |
| 1Y | 33.2% | -24.2% | -15.1% |
Return vs Industry: 688278 exceeded the CN Biotechs industry which returned -24.2% over the past year.
Return vs Market: 688278 exceeded the CN Market which returned -15.1% over the past year.
Price Volatility
| 688278 volatility | |
|---|---|
| 688278 Average Weekly Movement | 7.6% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 688278 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688278's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,960 | Li Sun | www.amoytop.com |
Xiamen Amoytop Biotech Co., Ltd. engages in the manufacture, marketing, and sale of recombinant protein drugs in China. It provides solutions for diseases, such as viral hepatitis, malignant tumors, and immunotherapy. The company was founded in 1996 and is based in Xiamen, China.
Xiamen Amoytop Biotech Co., Ltd. Fundamentals Summary
| 688278 fundamental statistics | |
|---|---|
| Market cap | CN¥24.35b |
| Earnings (TTM) | CN¥600.08m |
| Revenue (TTM) | CN¥2.23b |
40.6x
P/E Ratio10.9x
P/S RatioIs 688278 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688278 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.23b |
| Cost of Revenue | CN¥143.19m |
| Gross Profit | CN¥2.08b |
| Other Expenses | CN¥1.48b |
| Earnings | CN¥600.08m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.48 |
| Gross Margin | 93.57% |
| Net Profit Margin | 26.95% |
| Debt/Equity Ratio | 0.2% |
How did 688278 perform over the long term?
See historical performance and comparison